(Clin. Chem. 28:659-661, 1982) is applied here to tobramycm, phenobarbital,and theophyiline. Only 10-50 zL of test sample is needed. No sample treatment, dilution, or extrachon is required. A test serum sample is simultaneously mixed with a drug conjugate and its specific antiserum in a centrifugal analyzer. The subsequent reaction and the measurement are completed in 3 mm. Within-run and between-run CVs for clinically relevant concentrations were well below 10%. Resuits for patients' samples correlated well with those by enzyme immunoassay.
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We first reported spectrophotometry of haptens in serum by homogeneous immunoprecipitation assay, performed in a centrifugal analyzer (1). Assays for some drugs were later described (2, 3) . Here, we have applied this technique to the quantification of tobramycin, theophylline, and phenobarbital in serum.
Materials and Methods

Apparatus.
We used a GEMSNI centrifugal analyzer (Electro-Nucleonics, Inc., Fairfield, NJ 07006). The microprocessor that is part of this analyzer calculates the absorbance change at 340 nm for each standard and test sample.
Reagents. As immunogens we used conjugates of 1-(Ncarboxybutyflphenobarbital and 8-(carboxypropyi)theophylline, respectively, with bovine serum albumin. We synthesized the former by a modification of the procedure of Henze and Spurlock (4), the latter by the procedure of Cook et al. 
Standards.
Standards of tobramycin, phenobarbital, and theophylline were dissolved in drug-free, hepatitis-negative normal human serum to give the appropriate concentra- 
Procedure:
We used a procedure similar to that for gentamicin, with the GEMENI centrifugal analyzer, which has been described in detail (2) . We used 50 tL of patient's serum for tobramycin assay and 10 zL for either phenobarbital or theophylline assay by the present method.
Results and DIscussIon
Reaction kinetics. Figure 1 illustrates the time dependence of the absorbance. The turbidiinetric curves of absorbance vs time for tobramycin are quite different from those of phenobarbital and theophylline, indicating that the aggregation process in the case of tobramycin differs from that for phenobarbital and theophylline. The antibody-antigen reaction and the subsequent formation of the precipitate occurs in three steps (9-14):
Step present assay with a homogeneous enzyme immunoassay (zrirr; Syva Co., Palo Alto, CA 94304), assaying the same patients' specimens by each method. The resulting correlation, as determined by linear regression analysis, is shown in Figure 3 . The coefficient of correlation for the two methods in the case of tobramycin is 0.87 (138 patients' samples); for both phenobarbital and theophylline it is 0.97 (>100 patients' samples).
Specificity.
We tested certain clinically relevant components or structurally similar compounds that might cross react with the antibody used in the present method. Cross For the theophylline assay, there was no cross reactivity with hypoxanthine, phenobarbital, urea, or 3-methylxanthine, in concentrations of 100 mg/L. Caffeine, theobromine, 8-chlorotheophylline, and 7-(2,3)-dihydroxypropyltheophylline showed measurable cross reactivity both in this assay and other immunoassays for theophylline (5, 17) . A dietary source of caffeine is coffee and some cola beverages, as well as several widely used over-the-counter medications. Reportedly, eight cups of coffee (about 640 mg of caffeine), taken during 7 h, will produce a peak caffeine concentration in serum of about 4.0 mg/L (17-19) .
Such a concentration could measurably interfere in the present theophylline assay. The major caffeine metabolites-theophylline, theobromine, and dimethylxanthine-will be present in serum in concentrations of <1 mg/L in individuals given 300 mg of caffeine (17, 20) . These amounts would not interfere in the clinical assay.
In the assays reported here, none of the patients' samples were diluted or pretreated in any way. The imprecision of the present method is well below 10%. This method seems to be the simplest as compared with present widely used methods in that it involves no radioactive isotope, enzyme activity, or fluorescent tag. As with the enzyme immunoassay procedure, the present method depends on simple and precise spectrophotometry, and so is flexible enough to be run used with a wide variety of instrumentation, which includes but is not limited to centrifugal analyzers. Dedicated instrumentation is not necessary.
